查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917884

临终关怀市场－2026-2031年预测

Hospice Care Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 130 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2025 年，临终关怀市场规模将达到 842.79 亿美元，到 2031 年将达到 1,219.64 亿美元，复合年增长率为 6.35%。

临终关怀市场是医疗保健体系中一个重要且不断增长的组成部分，致力于为身患绝症的患者提供富有同情心的跨学科护理。这种专业化的照护模式优先考虑透过专业的疼痛和症状管理来提高患者的生活质量，同时为患者及其家属提供心理社会和精神支持。市场成长的驱动因素包括强劲且持续的人口结构变化、社会对临终关怀日益增长的接受度，以及医疗保健系统越来越重视将安宁疗护原则和基于价值的照护模式融入其中。

市场扩张最显着且不可逆转的驱动因素源于全球人口老化趋势以及慢性病和末期盛行率的不断上升。随着人口老化，诸如进行性癌症、末期器官衰竭和神经退化性疾病等复杂进行性疾病的发生率显着增加。这种人口结构现实导致越来越多的患者不再以治癒性治疗为目标；治疗的重点转向了舒适、尊严和支持。临终关怀在满足这一人群的多方面需求方面具有独特的优势，确保了对临终关怀服务的基本且不断增长的需求，而这种需求与更广泛的公共卫生趋势直接相关。

与人口结构变化相伴随的是，人们对临终关怀的认知和接受度显着提高，并将其视为优质医疗保健的组成部分。面向大众和医疗保健专业人员的教育活动已逐步改变人们的观念，并减少了以往对临终关怀的偏见和误解。病人、家属和转诊医生越来越认识到早期整合安宁疗护和临终关怀服务的益处。这与病人和家属满意度的提高、医院再入院率的降低以及更符合病人目标的照护密切相关。这种将临终关怀视为积极支持性选择而非「遗弃」象征的文化转变，正在扩大患者群体，并鼓励更早进行转诊。

安宁疗护和疼痛管理的进步是其日益被接受的关键基础，也是市场的主要驱动力。针对症状管理（包括顽固性疼痛、呼吸困难和谵妄）的药物和非药物策略的持续创新，使临终关怀团队能够提供更有效、更先进的安宁疗护。实证通讯协定的采用和专业治疗方法的整合，使医护人员能够在各种护理环境中管理复杂的症状，从而改善患者预后，并增强专业临终关怀服务的提案。这种临床专业知识在实现有尊严、舒适的生命终点体验方面发挥着核心作用。

此外，该市场的一个显着特征是越来越重视提供尊重病人自主权、个人价值观和生活品质的医疗服务。这种以患者为中心的理念不仅限于身体症状管理，还包括为患者提供全面的情感、心理和社会支持，以及为患者家属提供哀伤辅导服务。随着医疗保健消费者和支付方越来越重视尊重个人意愿并在重大变故时期为家庭提供支持的医疗服务，对这种全面、充满关怀的医疗模式的需求成为强劲的成长要素。

从地理位置来看，北美是一个成熟且重要的市场。完善的监管和报销体系，特别是美国的联邦医疗保险临终关怀福利计划（Medicare Hospice Benefit Plan），为服务提供和资金筹措提供了清晰的框架，从而巩固了北美市场的地位。此外，该地区还拥有高密度的专科医疗机构、丰富的临床经验以及公众对临终关怀选择的较高认知度。这些因素共同建构了一个强大的临终关怀服务提供和创新生态系统。

市场上的服务提供方式根据不同的服务模式进行细分，以满足患者多样化的需求和偏好。目前，居家照护仍是主流模式，帮助患者留在熟悉的环境中。此外，服务提供者还提供急性危机情况下的持续居家照护、针对需要住院治疗的复杂疾病的住院护理，以及为家庭看护者提供的喘息服务。领先的医疗机构通常会提供这种全面的连续性护理服务，并由医生、护士、社工、牧师和志工组成的多学科团队提供支援。

竞争格局由大规模全国性医疗机构、区域组织和非营利组织组成。成功机构的关键优势包括：能够在不同地域提供高品质、一致的医疗服务；与医院和医疗系统内的转诊机构建立牢固的关係；有效利用技术进行医疗协调；以及能够应对复杂的监管和报销环境。透过併购进行策略整合是一大趋势，旨在扩大规模、拓展地理覆盖范围，并在更广泛的以价值为导向的医疗网络中深化服务整合。

总之，临终关怀市场正受到深刻的人口和社会因素的影响而不断发展。其成长得益于结构性因素：全球人口老化以及慢性、危及生命的疾病的增加。未来的发展将取决于在疾病早期阶段持续融入临终关怀理念、安宁疗护科学的进一步进步，以及能够奖励高品质和以患者为中心的治疗结果的永续支付模式的建立。对于医疗服务提供者而言，成功的关键在于他们能否有效应对医疗保健环境中复杂的营运和财务挑战，同时始终如一地提供卓越、充满关怀的护理，真正尊重患者及其家属的尊严。

本报告的主要优势：

  • 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在动态环境中做出策略决策，并开拓新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

您打算如何使用这份报告？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章 按类型分類的临终关怀市场

  • 介绍
  • 日常居家照护
  • 普通住院护理
  • 持续护理
  • 临时照护

第六章 按年龄组别分類的临终关怀市场

  • 介绍
  • 孩子们
  • 成人
  • 老年人

第七章 以最终用户分類的临终关怀市场

  • 介绍
  • 医院
  • 护理机构
  • 自己的家

第八章：各地区的临终关怀市场

  • 介绍
  • 北美洲
    • 按类型
    • 按年龄组
    • 最终用户
    • 按国家/地区
      • 我们
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按类型
    • 按年龄组
    • 最终用户
    • 按国家/地区
      • 巴西
      • 阿根廷
      • 其他的
  • 欧洲
    • 按类型
    • 按年龄组
    • 最终用户
    • 按国家/地区
      • 德国
      • 法国
      • 英国
      • 西班牙
      • 义大利
      • 其他的
  • 中东和非洲
    • 按类型
    • 按年龄组
    • 最终用户
    • 按国家/地区
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 其他的
  • 亚太地区
    • 按类型
    • 按年龄组
    • 最终用户
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 印尼
      • 泰国
      • 台湾
      • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Amedisys Inc.
  • Chemed Corporation
  • Humana Inc.
  • LHC Group, Inc.
  • AccentCare Inc.
  • Compassus
  • Enhabit Home Health & Hospice.
  • Gentiva
  • Crossroads Hospice & Palliative Care
  • Caris Healthcare, LP

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615951

Hospice Care Market, at a 6.35% CAGR, is anticipated to reach USD 121.964 billion in 2031 from USD 84.279 billion in 2025.

The hospice care market constitutes a vital and expanding segment of the healthcare continuum, dedicated to providing compassionate, interdisciplinary care for individuals with life-limiting illnesses. This specialized care model prioritizes enhancing quality of life through expert pain and symptom management, alongside providing psychosocial and spiritual support for both patients and their families. The market's growth is propelled by powerful, sustained demographic shifts, evolving societal acceptance of end-of-life care, and an increasing emphasis within healthcare systems on integrating palliative principles and value-based care models.

The most significant and irreversible driver of market expansion is the global demographic trend toward an aging population, coupled with the rising prevalence of chronic and terminal illnesses. As populations age, the incidence of complex, progressive conditions such as advanced cancer, end-stage organ failure, and neurodegenerative diseases increases substantially. This demographic reality creates a growing cohort of patients for whom curative treatment is no longer the goal, shifting the focus to comfort, dignity, and support. Hospice care is uniquely positioned to address the multifaceted needs of this population, ensuring a fundamental and expanding demand for its services that is directly linked to broader public health trends.

Parallel to this demographic driver is a marked increase in the awareness and acceptance of hospice care as a standard component of high-quality medical treatment. Public and professional education initiatives have progressively reshaped perceptions, reducing historical stigma and misconceptions about end-of-life care. There is greater recognition among patients, families, and referring physicians of the benefits of early integration of palliative and hospice services, which are associated with improved patient and family satisfaction, reduced hospital readmissions, and more aligned care consistent with patient goals. This cultural shift toward viewing hospice as a proactive, supportive choice rather than a signal of abandonment is broadening the eligible patient base and encouraging earlier referrals.

Advancements in palliative medicine and pain management are critical enablers of this growing acceptance and are, in themselves, key market drivers. Continuous innovation in pharmacologic and non-pharmacologic strategies for symptom control-including refractory pain, dyspnea, and delirium-allows hospice teams to provide more effective and sophisticated comfort care. The adoption of evidence-based protocols and the integration of specialized therapies enable providers to manage complex symptoms in various care settings, thereby improving patient outcomes and reinforcing the value proposition of specialized hospice services. This clinical expertise is central to delivering on the promise of a dignified and comfortable end-of-life experience.

The market is further characterized by an increasing emphasis on providing care that honors patient autonomy, personal values, and the holistic concept of quality of life. This patient-centered philosophy extends beyond physical symptom management to encompass comprehensive emotional, psychosocial, and spiritual support for patients and bereavement services for families. The demand for this holistic, compassionate model of care is a powerful growth vector, as healthcare consumers and payers increasingly value care delivery that respects individual preferences and supports families through a profound transition.

Geographically, North America represents a mature and leading market. This position is supported by a well-established regulatory and reimbursement framework, particularly within the Medicare Hospice Benefit in the United States, which provides a clear structure for service delivery and financing. The region also benefits from a high density of specialized providers, extensive clinical experience, and a relatively high level of public awareness regarding hospice options. These factors combine to create a robust ecosystem for hospice care delivery and innovation.

Service delivery within the market is segmented across various settings to meet diverse patient needs and preferences. The dominant setting remains routine home care, allowing patients to remain in a familiar environment. However, providers also offer continuous home care during acute crises, general inpatient care for complex symptom management requiring hospitalization, and respite care to support family caregivers. Leading organizations typically provide this full continuum, supported by interdisciplinary teams of physicians, nurses, social workers, chaplains, and volunteers.

The competitive landscape features a mix of large national providers, regional organizations, and non-profit entities. Key differentiators for successful organizations include the ability to provide high-quality, consistent care across geographic regions, strong relationships with referral sources in hospitals and health systems, effective utilization of technology for care coordination, and the capacity to manage the complex regulatory and reimbursement landscape. Strategic consolidation through mergers and acquisitions has been a notable trend, aimed at achieving scale, expanding geographic reach, and integrating services more deeply within broader value-based care networks.

In conclusion, the hospice care market is evolving in response to profound demographic and societal forces. Its growth is structurally supported by an aging global population and the increasing burden of chronic, life-limiting illness. Future expansion will be shaped by the continued integration of hospice principles earlier in the disease trajectory, further advancements in palliative symptom science, and the development of sustainable payment models that reward quality and patient-centered outcomes. Success for providers will depend on their ability to deliver consistently excellent, compassionate care that truly honors the dignity of patients and families, while effectively navigating the operational and financial complexities of the healthcare environment.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Hospice Care Market Segmentation

  • By Type
  • Routine Home Care
  • General Inpatient Care
  • Continuous Care
  • Respite Care
  • By Age Group
  • Children
  • Adult
  • Elderly
  • By End-User
  • Hospitals
  • Nursing Centers
  • Homes
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HOSPICE CARE MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Routine Home Care
  • 5.3. General Inpatient Care
  • 5.4. Continuous Care
  • 5.5. Respite Care

6. HOSPICE CARE MARKET BY AGE GROUP

  • 6.1. Introduction
  • 6.2. Children
  • 6.3. Adult
  • 6.4. Elderly

7. HOSPICE CARE MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Nursing Centers
  • 7.4. Homes

8. HOSPICE CARE MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Age Group
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Age Group
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Age Group
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Age Group
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Age Group
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Amedisys Inc.
  • 10.2. Chemed Corporation
  • 10.3. Humana Inc.
  • 10.4. LHC Group, Inc.
  • 10.5. AccentCare Inc.
  • 10.6. Compassus
  • 10.7. Enhabit Home Health & Hospice.
  • 10.8. Gentiva
  • 10.9. Crossroads Hospice & Palliative Care
  • 10.10. Caris Healthcare, L.P.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations